Lash Litigation & Regulation Timeline
Key lawsuits, recalls, and regulatory actions affecting lash-growth cosmetics (2018–2026)
Rodan + Fields Lash Boost suits filed
Lewis consolidated complaint in N.D. Cal.
Ribak filed against Grande Cosmetics
Mandel and Nixon filed against Grande
EU adopts Regulation 2022/1181 on formaldehyde-releaser warning threshold
SCCS flags concerns about prostaglandin analogues in cosmetics
California approves $38M Lash Boost settlement
Health Canada recalls EyEnvy, FEG, Revive 7 and other lash serums for undeclared PGA ingredients
EU Safety Gate alert on eyelash serum with cloprostenol isopropyl ester
Slattery filed against Athena
MoCRA serious adverse event reporting becomes operational in U.S.
Health Canada cyanoacrylate lash-adhesive compliance project issues multiple stop-sales
Cohen filed against Elixir/Babe Lash in E.D.N.Y.
Markoff and Rush Athena actions advance
Nixon v. Grande receives final approval
UK OPSS publishes prostaglandin analogues in cosmetics review
FDA launches public cosmetic adverse-event dashboard
Babe Lash settlement receives final approval
EU Safety Gate issues additional lash-serum alerts including bimatoprost
SCCS concludes assessed lash-growth prostaglandin analogues are not safe in cosmetics
Athena / RevitaLash settlement receives final approval